Reduction in tumor stain at 2 weeks after treatment initiation is a predictor of the efficacy of lenvatinib in patients with unresectable hepatocellular carcinoma

o1893

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

https://fukuoka-u.repo.nii.ac.jp/record/5285/files/o1893.pdf

内容の要旨及び結果の要旨

application/pdf

ファイル	ライセンス
o1893.pdf (564.9 kB) sha256 d2bac27997f61f098d8ba68267fc971319a0d82e41487b051170844068df5bcd

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays